Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02713828
Title Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung
Acronym PrE0504
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PrECOG, LLC.
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.